Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Cash from Financing Activities (2009 - 2026)

Icon's (ICLR) quarterly Cash from Financing Activities came in at -$8.1 million in Q2 2026, up 96.83% year-over-year from -$4.1 million in Q2 2025, and down 27.65% quarter-over-quarter from -$6.4 million in Q1 2026.

Analysis

Icon (ICLR) Cash from Financing Activities (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Cash from Financing Activities for 18 consecutive years, with -$8.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Financing Activities rose 96.83% year-over-year to -$8.1 million in Q2 2026; TTM through Jun 2026 was -$319.0 million, a 69.85% increase from a year earlier, with the FY2025 full-year figure at -$813.2 million, up 8.1% from the prior year.
  • Cash from Financing Activities was -$8.1 million for Q2 2026 at Icon, down from -$6.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at -$6.4 million in Q1 2026 and troughed at -$451.7 million in Q4 2024.
  • A 5-year average of -$190.0 million and a median of -$189.7 million in 2022 frame the typical range for Cash from Financing Activities.
  • Across the five-year window, Cash from Financing Activities slumped 53792.44% in 2022 and jumped 97.49% in 2026, its largest moves.
  • Over 5 years, Cash from Financing Activities stood at -$193.1 million in 2022, then sank by 32.31% to -$255.5 million in 2023, then slumped by 76.75% to -$451.7 million in 2024, then soared by 89.42% to -$47.8 million in 2025, then jumped by 83.01% to -$8.1 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$8.1 million (Q2 2026), -$6.4 million (Q1 2026), and -$47.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn -214.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn -288.34 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -8.12 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn -164.66 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn -
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 16.49 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 33,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 248,151.59
10 VivoSim Labs 1.37 Mn 1.37 Mn - -118,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -8.12 Mn
Mar 31, 2026 -6.36 Mn
Dec 31, 2025 -47.78 Mn
Sep 30, 2025 -256.77 Mn
Jun 30, 2025 -255.86 Mn
Mar 31, 2025 -252.83 Mn
Dec 31, 2024 -451.69 Mn
Sep 30, 2024 -97.78 Mn
Jun 30, 2024 -71.75 Mn
Mar 31, 2024 -263.70 Mn
Dec 31, 2023 -255.55 Mn
Sep 30, 2023 -258.67 Mn
Jun 30, 2023 -172.77 Mn
Mar 31, 2023 -157.06 Mn
Dec 31, 2022 -193.14 Mn
Sep 30, 2022 -186.17 Mn
Jun 30, 2022 -92.35 Mn
Mar 31, 2022 -392.51 Mn
Dec 31, 2021 -485.47 Mn
Sep 30, 2021 5.60 Bn